These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26780168)

  • 1. Liposome Based Intravesical Therapy Targeting Nerve Growth Factor Ameliorates Bladder Hypersensitivity in Rats with Experimental Colitis.
    Kawamorita N; Yoshikawa S; Kashyap M; Tyagi P; Arai Y; Chancellor MB; Yoshimura N
    J Urol; 2016 Jun; 195(6):1920-6. PubMed ID: 26780168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
    Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
    Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder.
    Kashyap M; Kawamorita N; Tyagi V; Sugino Y; Chancellor M; Yoshimura N; Tyagi P
    J Urol; 2013 Aug; 190(2):757-64. PubMed ID: 23454160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of nerve growth factor-targeting therapy on bladder overactivity in rats with prostatic inflammation.
    Igarashi T; Tyagi P; Mizoguchi S; Saito T; Furuta A; Suzuki Y; Egawa S; Wang Z; Yoshimura N
    Prostate; 2021 Dec; 81(16):1303-1309. PubMed ID: 34596255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of liposome-based local suppression of nerve growth factor in the bladder on autonomic dysreflexia during urinary bladder distention in rats with spinal cord injury.
    Kadekawa K; Yoshizawa T; Wada N; Shimizu T; Majima T; Tyagi P; de Groat WC; Sugaya K; Yoshimura N
    Exp Neurol; 2017 May; 291():44-50. PubMed ID: 28174025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
    Chuang YC; Lee WC; Lee WC; Chiang PH
    J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic organ cross-sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis.
    Yoshikawa S; Kawamorita N; Oguchi T; Funahashi Y; Tyagi P; Chancellor MB; Yoshimura N
    Neuroscience; 2015 Jan; 284():422-429. PubMed ID: 25445197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides.
    Ustinova EE; Gutkin DW; Pezzone MA
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F123-30. PubMed ID: 16926445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat.
    Fraser MO; Chuang YC; Tyagi P; Yokoyama T; Yoshimura N; Huang L; De Groat WC; Chancellor MB
    Urology; 2003 Mar; 61(3):656-63. PubMed ID: 12639679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability.
    Greenwood-Van Meerveld B; Mohammadi E; Latorre R; Truitt ER; Jay GD; Sullivan BD; Schmidt TA; Smith N; Saunders D; Ziegler J; Lerner M; Hurst R; Towner RA
    Urology; 2018 Jun; 116():230.e1-230.e7. PubMed ID: 29545038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity.
    Tyagi P; Hsieh VC; Yoshimura N; Kaufman J; Chancellor MB
    BJU Int; 2009 Dec; 104(11):1689-92. PubMed ID: 19594739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes.
    Chuang YC; Tyagi P; Huang CC; Yoshimura N; Wu M; Kaufman J; Chancellor MB
    J Urol; 2009 Aug; 182(2):786-92. PubMed ID: 19539320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor.
    Chuang YC; Fraser MO; Yu Y; Chancellor MB; de Groat WC; Yoshimura N
    J Urol; 2001 Mar; 165(3):975-9. PubMed ID: 11176525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?
    Digesu GA; Tailor V; Bhide AA; Khullar V
    Int Urogynecol J; 2020 Jul; 31(7):1387-1392. PubMed ID: 32358624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome - A pilot study.
    Mishra NN; Riedl C; Shah S; Pathak N
    Int J Urol; 2019 Jun; 26 Suppl 1():68-72. PubMed ID: 31144739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates.
    Tyagi P; Banerjee R; Basu S; Yoshimura N; Chancellor M; Huang L
    Mol Pharm; 2006; 3(4):398-406. PubMed ID: 16889433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical hyaluronidase causes chronic cystitis in a rat model: a potential model of bladder pain syndrome/interstitial cystitis.
    Lv YS; Yao YS; Rong L; Lin ME; Deng BH; Xie Y; Huang H; Lin TX; Xu KW; Huang J
    Int J Urol; 2014 Jun; 21(6):601-7. PubMed ID: 24286489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats.
    Chuang YC; Yoshimura N; Huang CC; Chiang PH; Chancellor MB
    J Urol; 2004 Oct; 172(4 Pt 1):1529-32. PubMed ID: 15371885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis.
    Gao D; Wagner AH; Fankhaenel S; Stojanovic T; Schweyer S; Panzner S; Hecker M
    Gut; 2005 Jan; 54(1):70-7. PubMed ID: 15591506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.